Machinify

Name: Machinify
Brand: Machinify

Machinify is a healthcare payment integrity software-and-services platform that applies AI-driven decisioning, configurable policy libraries, and human clinical/coding validation to support pre-pay and post-pay claims workflows, improve payment accuracy, and reduce administrative waste.

Est 2015|Valuation $31.3M|Raised $12.4M|2 Ref Customers

LinkedIn 12K|Web traffic 15K|FTEs 584

MarketsFraud Detection

Published Aug 13, 2026

01Common complaints

1) **Need fast, lightweight deployment with minimal integration** - Payment integrity platforms generally require integration effort; Machinify’s value depends on data integration and workflow alignment. 2) **Require abundant public customer reviews and third-party scoring** - Compared to SMB SaaS, Machinify has limited public review presence; organizations relying heavily on public review sites may find due diligence more difficult. 3) **Seeking a single-module point solution** - If the need is narrowly scoped (e.g., only prospective editing or a specific audit niche), a specialized competitor may deliver faster ROI with less organizational change. 4) **Concerned about post-merger execution risk** - Machinify’s consolidation and acquisitions in 2025 can increase the risk of uneven module maturity and support transitions during integration. 5) **Require publicly documented ISO certifications and detailed security control transparency** - While HITRUST and SOC 2 statements exist, many enterprise security details are not fully described in public sources.

Deal disqualifiers (poor fit)

Very small plans without scale to justify enterprise implementation
Organizations that require transparent public pricing and self-serve trials
Organizations unable to support the data readiness and integration work required for deployment

Publicly acknowledged limitations

Machinify’s compliance page notes ongoing work to integrate subsidiaries toward common compliance standards, implying transitional complexity.

Likely limitations / diligence topics

- **Product unification maturity:** Procurement should clarify which components are fully unified and which continue to operate as legacy modules. - **Auth product scope change:** The company announced that its Auth application was acquired by Evolent; this affects buyers seeking an end-to-end suite from a single vendor. - **API and integration constraints:** Public documentation is limited; procurement should request API documentation, data schemas, and supported interoperability standards.

Roadmap visibility

Public roadmap details with dates were not found in reviewed sources; procurement should request a roadmap and contractual commitments for must-have features.

02Why they buy

Potential differentiators (partially validated)

- **Breadth across the claims lifecycle:** Company materials indicate the suite spans audit and payment workflows; prior authorization capability was historically part of the offering prior to a separate transaction. - **Complex claim audit focus with combined AI and human validation:** The Audit module targets DRGs, implants, high-cost drugs, NICU leveling, outpatient/modifiers, and behavioral health reviews. - **Scale claims (vendor stated):** The company states deployments across 60+ health plans / 160M lives and large cost-avoidance figures, which suggest market traction but require independent validation.

Where competitors may have clear advantages

Optum: Breadth, scale, a mature services organization, and deep payer relationships.
HealthEdge Source: A focused prospective integrity product and related ecosystem partnerships.

03Field reports

Review platform availability reality check

For Machinify as a payer-focused enterprise platform, mainstream SMB review sites (G2, Capterra) may have limited or no relevant product reviews. Searches more commonly surface meta-discussion about those platforms rather than extensive product-level feedback for enterprise payer solutions.

Industry-specific research appears more relevant for payer-focused enterprise evaluations.

Industry analyst / research snippets (customer experience)

Industry research firms have published First Look–style reporting on Machinify post-consolidation; detailed data is behind analyst portals.

Community/social commentary

Public forums did not show prominent, high-volume discussion of Machinify’s payer product in the sampled searches, which is consistent with a niche B2B buyer audience.

Employee sentiment as a proxy signal (not a substitute for customer reviews)

Because direct customer reviews are scarce publicly, employee reviews can provide indirect signals about execution risk, delivery maturity, and operational strain. **Glassdoor employee sentiment:** Poorly rated on Glassdoor in sampled snapshots. **Selected employee feedback (paraphrased):** - Some reviewers described pay changes and a challenging environment with management and turnover concerns. - Reports of workload and compensation issues appeared in some reviews. - At least one senior engineering review criticized leadership transparency and decision processes. **Selected positive signals:** - Some reviews during merger transition noted cultural strengths and benefit improvements. - Remote work flexibility and opportunities related to modernizing legacy technologies were mentioned. **Interpretation:** Employee reviews suggest integration and transition risk, potential management and culture issues, and possible compensation competitiveness concerns. These may translate into product delivery and support risks but are not direct evidence of customer satisfaction.

Reasons customers might cite for choosing Machinify (inferred from vendor materials and market logic)

Consolidating fragmented payment integrity vendors and workflows into a more unified vendor stack.
Accessing clinical and coding validation at scale for complex claim types and itemized bill review.
Interest in shifting payment integrity earlier in the adjudication lifecycle (pre-pay) rather than relying solely on post-pay recovery.

Reasons customers might not choose or might churn (inferred)

Preference for large incumbents with broader suites and established enterprise agreements.
Concerns about vendor consolidation complexity and integration timelines.
Skepticism about AI-related outcomes without transparent methods and independently validated results.

Vendor-published outcomes (examples)

Machinify publishes outcome metrics on its product pages and in press materials. Examples of vendor-published claims include: - Audit product page: claims of substantial annual cost avoidance and average reductions in complex claim spend. - Press releases citing that automation enabled a major payer to handle a significant portion of recoveries without human review and reported additional recoveries. - Vendor statements referencing large-scale annual cost savings across deployments.

Critical evaluation (methodology gaps)

- These outcomes are vendor-published and typically do not disclose baseline definitions (which spend categories were included), time windows, controls or comparators, whether savings are gross vs net of vendor fees and operational costs, or how disputes and appeals were treated. **Recommendation for procurement teams:** Request a savings methodology document and references willing to discuss: - Hit-rate changes - Provider abrasion or dispute rates - Clinical reviewer productivity - Net savings after fees and staffing - Ramp time and data readiness challenges

Limited visibility into negative outcomes

Public case studies describing failed deployments were not found in the reviewed sample. Given the enterprise nature of this market, such information often remains private; procurement should request lessons-learned examples and situations where modules underperformed and detail what was changed.

04Best fit

Company sizes

Best fit: Mid-to-large U.S. health plans (regional to national). The company states deployments across a large number of health plans and covered lives, implying readiness for complex enterprise scale.

Industries / verticals

Health insurance payers (commercial, Medicare Advantage, Medicaid managed care)
Government programs following the Performant acquisition (payment accuracy and improper payment recovery contexts)

Roles and personas

Decision makers: Payment integrity and claims operations leadership, payer CIO/CTO, clinical leadership, and security/compliance stakeholders.
End users: Payment integrity analysts, nurses/clinical reviewers, coders, audit operations leaders, recovery teams, SIU, and provider relations.

Pain points addressed

Administrative cost and waste in claims operations
Fragmented payment integrity vendors and tool sprawl
Need to improve payment accuracy earlier in the lifecycle (pre-pay)
Scaling clinical and coding reviews without linear headcount growth

Qualification criteria (good fit)

Sufficient claim volume where automation can yield meaningful ROI
Willingness to invest in integration and operating model modernization
Appetite for AI-assisted clinical and coding validation with governance and auditability

05The pitch

What the product does (objective value proposition)

Machinify is a healthcare payment integrity and healthcare administration software-and-services platform used primarily by health plans (payers) to improve claim payment accuracy and reduce administrative waste. The solution uses artificial intelligence and machine learning models to support pre-pay and post-pay workflows across the claims lifecycle—identifying suspect claims, validating clinical and coding accuracy against records, enforcing payment policy and contract terms, and supporting recovery and related payment integrity functions. The offering combines: - A configurable software platform positioned as an AI-based decisioning platform used to operationalize decisioning - Content libraries (clinical, coding, and billing rules aligned to payer policy) - Human clinical and coding expertise for validation and defensibility (a hybrid model)

Target market and positioning

Primary buyers: U.S. health plans (national and regional), and government program contractors/participants following the Performant acquisition.
Positioning: A payment integrity platform that seeks to shift some payment integrity activities upstream (pre-pay) and to reduce reliance on manual review and fragmented vendor stacks.

Get a comprehensive analysis of Machinify including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

Published Aug 13, 2026

01Common complaints

Need fast, lightweight deployment with minimal integration

Payment integrity platforms generally require integration effort; Machinify’s value depends on data integration and workflow alignment.

Require abundant public customer reviews and third-party scoring

Compared to SMB SaaS, Machinify has limited public review presence; organizations relying heavily on public review sites may find due diligence more difficult.

Seeking a single-module point solution

If the need is narrowly scoped (e.g., only prospective editing or a specific audit niche), a specialized competitor may deliver faster ROI with less organizational change.

Concerned about post-merger execution risk

Machinify’s consolidation and acquisitions in 2025 can increase the risk of uneven module maturity and support transitions during integration.

Require publicly documented ISO certifications and detailed security control transparency

While HITRUST and SOC 2 statements exist, many enterprise security details are not fully described in public sources.

Deal disqualifiers (poor fit)

Very small plans without scale to justify enterprise implementation
Organizations that require transparent public pricing and self-serve trials
Organizations unable to support the data readiness and integration work required for deployment

Publicly acknowledged limitations

Machinify’s compliance page notes ongoing work to integrate subsidiaries toward common compliance standards, implying transitional complexity.

Likely limitations / diligence topics

Product unification maturity: Procurement should clarify which components are fully unified and which continue to operate as legacy modules.
Auth product scope change: The company announced that its Auth application was acquired by Evolent; this affects buyers seeking an end-to-end suite from a single vendor.
API and integration constraints: Public documentation is limited; procurement should request API documentation, data schemas, and supported interoperability standards.

Roadmap visibility

Public roadmap details with dates were not found in reviewed sources; procurement should request a roadmap and contractual commitments for must-have features.

02Why they buy

Potential differentiators (partially validated)

Breadth across the claims lifecycle: Company materials indicate the suite spans audit and payment workflows; prior authorization capability was historically part of the offering prior to a separate transaction.
Complex claim audit focus with combined AI and human validation: The Audit module targets DRGs, implants, high-cost drugs, NICU leveling, outpatient/modifiers, and behavioral health reviews.
Scale claims (vendor stated): The company states deployments across 60+ health plans / 160M lives and large cost-avoidance figures, which suggest market traction but require independent validation.

Where competitors may have clear advantages

Optum: Breadth, scale, a mature services organization, and deep payer relationships.
HealthEdge Source: A focused prospective integrity product and related ecosystem partnerships.

03Field reports

Review platform availability reality check

Industry-specific research appears more relevant for payer-focused enterprise evaluations.

Industry analyst / research snippets (customer experience)

Industry research firms have published First Look–style reporting on Machinify post-consolidation; detailed data is behind analyst portals.

Community/social commentary

Public forums did not show prominent, high-volume discussion of Machinify’s payer product in the sampled searches, which is consistent with a niche B2B buyer audience.

Employee sentiment as a proxy signal (not a substitute for customer reviews)

Because direct customer reviews are scarce publicly, employee reviews can provide indirect signals about execution risk, delivery maturity, and operational strain.

Glassdoor employee sentiment: Poorly rated on Glassdoor in sampled snapshots.

Selected employee feedback (paraphrased):

Some reviewers described pay changes and a challenging environment with management and turnover concerns.
Reports of workload and compensation issues appeared in some reviews.
At least one senior engineering review criticized leadership transparency and decision processes.

Selected positive signals:

Some reviews during merger transition noted cultural strengths and benefit improvements.
Remote work flexibility and opportunities related to modernizing legacy technologies were mentioned.

Interpretation: Employee reviews suggest integration and transition risk, potential management and culture issues, and possible compensation competitiveness concerns. These may translate into product delivery and support risks but are not direct evidence of customer satisfaction.

Reasons customers might cite for choosing Machinify (inferred from vendor materials and market logic)

Consolidating fragmented payment integrity vendors and workflows into a more unified vendor stack.
Accessing clinical and coding validation at scale for complex claim types and itemized bill review.
Interest in shifting payment integrity earlier in the adjudication lifecycle (pre-pay) rather than relying solely on post-pay recovery.

Reasons customers might not choose or might churn (inferred)

Preference for large incumbents with broader suites and established enterprise agreements.
Concerns about vendor consolidation complexity and integration timelines.
Skepticism about AI-related outcomes without transparent methods and independently validated results.

Vendor-published outcomes (examples)

Machinify publishes outcome metrics on its product pages and in press materials. Examples of vendor-published claims include:

Audit product page: claims of substantial annual cost avoidance and average reductions in complex claim spend.
Press releases citing that automation enabled a major payer to handle a significant portion of recoveries without human review and reported additional recoveries.
Vendor statements referencing large-scale annual cost savings across deployments.

Critical evaluation (methodology gaps)

These outcomes are vendor-published and typically do not disclose baseline definitions (which spend categories were included), time windows, controls or comparators, whether savings are gross vs net of vendor fees and operational costs, or how disputes and appeals were treated.

Recommendation for procurement teams: Request a savings methodology document and references willing to discuss:

Hit-rate changes
Provider abrasion or dispute rates
Clinical reviewer productivity
Net savings after fees and staffing
Ramp time and data readiness challenges

Limited visibility into negative outcomes

Public case studies describing failed deployments were not found in the reviewed sample. Given the enterprise nature of this market, such information often remains private; procurement should request lessons-learned examples and situations where modules underperformed and detail what was changed.

04Best fit

Company sizes

Best fit: Mid-to-large U.S. health plans (regional to national). The company states deployments across a large number of health plans and covered lives, implying readiness for complex enterprise scale.

Industries / verticals

Health insurance payers (commercial, Medicare Advantage, Medicaid managed care)
Government programs following the Performant acquisition (payment accuracy and improper payment recovery contexts)

Roles and personas

Decision makers: Payment integrity and claims operations leadership, payer CIO/CTO, clinical leadership, and security/compliance stakeholders.
End users: Payment integrity analysts, nurses/clinical reviewers, coders, audit operations leaders, recovery teams, SIU, and provider relations.

Pain points addressed

Administrative cost and waste in claims operations
Fragmented payment integrity vendors and tool sprawl
Need to improve payment accuracy earlier in the lifecycle (pre-pay)
Scaling clinical and coding reviews without linear headcount growth

Qualification criteria (good fit)

Sufficient claim volume where automation can yield meaningful ROI
Willingness to invest in integration and operating model modernization
Appetite for AI-assisted clinical and coding validation with governance and auditability

05The pitch

What the product does (objective value proposition)

The offering combines:

A configurable software platform positioned as an AI-based decisioning platform used to operationalize decisioning
Content libraries (clinical, coding, and billing rules aligned to payer policy)
Human clinical and coding expertise for validation and defensibility (a hybrid model)

Target market and positioning

Primary buyers: U.S. health plans (national and regional), and government program contractors/participants following the Performant acquisition.
Positioning: A payment integrity platform that seeks to shift some payment integrity activities upstream (pre-pay) and to reduce reliance on manual review and fragmented vendor stacks.

Get a comprehensive analysis of Machinify including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →